基于超声的子宫内膜癌术前淋巴结转移风险预测模型:模型开发研究
在16个欧洲中心1501例术前接受经阴道超声的子宫内膜癌患者中,开发了结合子宫内膜活检结果及临床和超声变量的淋巴结转移预测模型;模型AUC为0.73,在5%与20%风险阈值下敏感度分别为98%与48%,特异度分别为11%与80%,判别能力优于单纯活检或活检联合超声的风险分类。
要点
- 模型纳入年龄、异常出血持续时间、活检结果、超声肿瘤范围与大小及子宫内膜不可测的未定义肿瘤。
- 5%风险阈值下敏感度98%、特异度11%;20%阈值下敏感度48%、特异度80%。
- 模型AUC 0.73,校准斜率1.06,校准截距0.06。
核心结论
- 基于子宫内膜活检结果及临床和超声特征,可在术前可靠估计子宫内膜癌患者的个体淋巴结转移风险,模型优于单纯活检或活检联合超声的风险分类。
研究设计与样本
- 混合效应逻辑回归预测模型开发研究,纳入1501例术前接受经阴道超声的子宫内膜癌患者,来自16个欧洲中心,缺失数据(含淋巴结状态)采用插补。
- 采用留中心交叉验证评估判别、校准与临床效用,并与单纯子宫内膜活检风险分类或活检联合超声风险分类进行比较。
关键影像表现/征象
- 模型预测因子包括年龄、异常出血持续时间、子宫内膜活检结果、超声所示肿瘤范围与肿瘤大小,以及子宫内膜不可测的未定义肿瘤。
诊断标准与关键数值
- 模型AUC为0.73(95% CI,0.68-0.78),校准斜率1.06(95% CI,0.79-1.34),校准截距0.06(95% CI,-0.15至0.27)。
- 淋巴结转移风险阈值5%时敏感度98%、特异度11%;20%阈值时敏感度48%、特异度80%。
- 单纯子宫内膜活检高风险定义(子宫内膜样癌G3/非子宫内膜样癌)敏感度35%、特异度77%;模型相应为50%与80%。
- 活检联合超声高风险定义(子宫内膜样癌G3/非子宫内膜样癌/深肌层浸润/宫颈间质浸润/宫外扩散)敏感度75%、特异度52%;模型相应为80%与53%。
临床应用与阅片要点
- 模型可在术前结合活检与超声变量个体化估计淋巴结转移风险,任意风险阈值下临床效用均高于单纯活检或活检联合超声。
- 原文未据此给出具体阅片推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop a preoperative risk model, using endometrial biopsy results and clinical and ultrasound variables, to predict the individual risk of lymph-node metastases in women with endometrial cancer.
METHODS: A mixed-effects logistic regression model for prediction of lymph-node metastases was developed in 1501 prospectively included women with endometrial cancer undergoing transvaginal ultrasound examination before surgery, from 16 European centers. Missing data, including missing lymph-node status, were imputed. Discrimination, calibration and clinical utility of the model were evaluated using leave-center-out cross validation. The predictive performance of the model was compared with that of risk classification from endometrial biopsy alone (high-risk defined as endometrioid cancer Grade 3/non-endometrioid cancer) or combined endometrial biopsy and ultrasound (high-risk defined as endometrioid cancer Grade 3/non-endometrioid cancer/deep myometrial invasion/cervical stromal invasion/extrauterine spread).
RESULTS: Lymphadenectomy was performed in 691 women, of whom 127 had lymph-node metastases. The model for prediction of lymph-node metastases included the predictors age, duration of abnormal bleeding, endometrial biopsy result, tumor extension and tumor size according to ultrasound and undefined tumor with an unmeasurable endometrium. The model's area under the curve was 0.73 (95% CI, 0.68-0.78), the calibration slope was 1.06 (95% CI, 0.79-1.34) and the calibration intercept was 0.06 (95% CI, -0.15 to 0.27). Using a risk threshold for lymph-node metastases of 5% compared with 20%, the model had, respectively, a sensitivity of 98% vs 48% and specificity of 11% vs 80%. The model had higher sensitivity and specificity than did classification as high-risk, according to endometrial biopsy alone (50% vs 35% and 80% vs 77%, respectively) or combined endometrial biopsy and ultrasound (80% vs 75% and 53% vs 52%, respectively). The model's clinical utility was higher than that of endometrial biopsy alone or combined endometrial biopsy and ultrasound at any given risk threshold.
CONCLUSIONS: Based on endometrial biopsy results and clinical and ultrasound characteristics, the individual risk of lymph-node metastases in women with endometrial cancer can be estimated reliably before surgery. The model is superior to risk classification by endometrial biopsy alone or in combination with ultrasound. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Eriksson LSE, Epstein E, Testa AC, et al. Ultrasound-based risk model for preoperative prediction of lymph-node metastases in women with endometrial cancer: model-development study. Ultrasound Obstet Gynecol. 2020. PMID: 31840873. doi:10.1002/uog.21950
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。